118 related articles for article (PubMed ID: 4007353)
41. [Protein binding of thromboxane--one of the sources of error in thromboxane determination].
Wirthumer-Hoche C; Sinzinger H
Wien Klin Wochenschr; 1985 Mar; 97(6):282-5. PubMed ID: 3993037
[TBL] [Abstract][Full Text] [Related]
42. Failure of thromboxane A2 blockade to prevent attacks of vasospastic angina.
Chierchia S; de Caterina R; Crea F; Patrono C; Maseri A
Circulation; 1982 Oct; 66(4):702-5. PubMed ID: 7116586
[TBL] [Abstract][Full Text] [Related]
43. Effect of elevated plasma-free fatty acids on thromboxane release in patients with coronary artery disease.
Lewy RI
Haemostasis; 1980; 9(3):134-40. PubMed ID: 7372200
[TBL] [Abstract][Full Text] [Related]
44. Platelet release and thromboxane synthesis in symptomatic coronary artery disease.
de Boer AC; Turpie AG; Butt RW; Johnston RV; Genton E
Circulation; 1982 Aug; 66(2):327-33. PubMed ID: 6212161
[TBL] [Abstract][Full Text] [Related]
45. [The prostacyclin-thromboxane system and the functional properties of the thrombocytes in patients of different ages with ischemic heart disease].
Ermakovich II; Ladnyĭ AI; Volkov VI; Tseluĭko VI
Vrach Delo; 1990 Sep; (9):25-8. PubMed ID: 2284757
[TBL] [Abstract][Full Text] [Related]
46. Regional left ventricular mechanical function during isometric exercise in patients with coronary artery disease: correlation with regional coronary blood flow changes.
Ferrara N; Vigorito C; Leosco D; Giordano A; Abete P; Longobardi G; Rengo F
J Am Coll Cardiol; 1988 Nov; 12(5):1215-21. PubMed ID: 3170962
[TBL] [Abstract][Full Text] [Related]
47. Thromboxane A2 as an enhancing factor of coronary vasospasticity in variant angina.
Ohmori M; Kuzuya T; Kodama K; Nanto S; Kamada T; Tada M
Jpn Circ J; 1987 May; 51(5):495-502. PubMed ID: 3626009
[TBL] [Abstract][Full Text] [Related]
48. Effects of dazoxiben on exercise performance in chronic stable angina.
Reuben SR; Kuan P; Cairns J; Gyde OH
Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):83S-86S. PubMed ID: 6402000
[TBL] [Abstract][Full Text] [Related]
49. Elevation of thromboxane B2 levels in patients with classic and variant angina Pectoris.
Tada M; Kuzuya T; Inoue M; Kodama K; Mishima M; Yamada M; Inui M; Abe H
Circulation; 1981 Dec; 64(6):1107-15. PubMed ID: 7296786
[No Abstract] [Full Text] [Related]
50. Effect of platelet depletion and inhibition of platelet cyclooxygenase on C5a-mediated myocardial ischemia.
Ito BR; Del Balzo U
Am J Physiol; 1994 Oct; 267(4 Pt 2):H1288-94. PubMed ID: 7943373
[TBL] [Abstract][Full Text] [Related]
51. [Assessment of the the physical loading tolerance of ischemic heart disease patients in relation to different sites of the coronary artery lesion].
Ianovskiĭ GV; Terzov AI; Belonozhko AG; Tsygankov AT; Radzivill VV
Ter Arkh; 1986; 58(12):55-7. PubMed ID: 3824214
[TBL] [Abstract][Full Text] [Related]
52. [Participation of the prostacyclin-thromboxane system in the mechanisms of prevention of arrhythmia caused by occlusion of the coronary artery in adapted rats].
Maslov LN; Khaliulin IG; Dvurechenskaia GIa; Barabash NA; Lishmanov IuB
Biull Eksp Biol Med; 1991 Jan; 111(1):16-8. PubMed ID: 1711383
[TBL] [Abstract][Full Text] [Related]
53. Effects of treadmill and pacing stress testing on peripheral arterial thromboxane, platelet function and catecholamine activities in patients with chronic coronary artery disease.
Kurita A; Satomura K; Takase B; Sugawara H; Hosono K
Jpn J Med; 1987 Feb; 26(1):7-14. PubMed ID: 2952824
[TBL] [Abstract][Full Text] [Related]
54. Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
Mehta J; Mehta P
Acta Med Scand Suppl; 1981; 651():111-21. PubMed ID: 6948499
[No Abstract] [Full Text] [Related]
55. Follow-up of in-vivo platelet function (platelet half-life, thromboxane B2) in patients with coronary heart disease.
Fitscha P; Kaliman J; Sinzinger H; Peskar BA
Vasa; 1984; 13(4):338-42. PubMed ID: 6516563
[No Abstract] [Full Text] [Related]
56. Thromboxane A2 in acute myocardial infarction.
Walinsky P; Smith JB; Lefer AM; Lebenthal M; Urban P; Greenspon A; Goldberg S
Am Heart J; 1984 Oct; 108(4 Pt 1):868-72. PubMed ID: 6485997
[TBL] [Abstract][Full Text] [Related]
57. Platelet function and exercise-induced myocardial ischaemia in coronary heart disease patients.
McGill D; McGuiness J; Lloyd J; Ardlie N
Thromb Res; 1989 Oct; 56(2):147-58. PubMed ID: 2533414
[TBL] [Abstract][Full Text] [Related]
58. Acute systemic and coronary hemodynamic and serologic responses to cigarette smoking in long-term smokers with atherosclerotic coronary artery disease.
Nicod P; Rehr R; Winniford MD; Campbell WB; Firth BG; Hillis LD
J Am Coll Cardiol; 1984 Nov; 4(5):964-71. PubMed ID: 6548482
[TBL] [Abstract][Full Text] [Related]
59. [Three infants with severe myocardial ischemia diagnosed by echocardiography: investigation of the cause of transient myocardial dysfunction].
Mitomori T; Baba K; Ohsaki M; Mitsudo K; Tanaka M
J Cardiol; 1991; 21(1):183-90. PubMed ID: 1817178
[TBL] [Abstract][Full Text] [Related]
60. Coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion in anaesthetised dogs.
Tanabe M; Terashita ZI; Fujiwara S; Shimamoto N; Goto N; Nishikawa K; Hirata M
Cardiovasc Res; 1982 Feb; 16(2):99-106. PubMed ID: 7074670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
